Free shipping on orders over $150
PEPTIDE LOGIX
Sign in
Selank 10mg research vial

peptides

Selank 10mg

Selank is a synthetic analog of tuftsin studied for anxiolytic effects without sedation, GABAergic modulation, and immunomodulatory action — typically administered intranasally.

Research-observed benefits

  • ›Calm focus
  • ›Anxiolytic profile
  • ›Immune modulation
  • ›Mood support

Findings reported in in-vitro / preclinical research literature. Not therapeutic claims.

Reconstitution helper

Suggested: 2 mL BAC water → 5.00 mg/mL

Open calculator →| Storage guide

CAS Number

—

Purity

99%+

Molecular Formula

—

Stock

220 units

Order type

Purchase option

Quantity

1

Total

$40

For in-vitro research only. Not for human consumption, diagnostic, or therapeutic use. Storage at -20°C recommended for lyophilized peptides.

Selank 10mg — Full Research Breakdown

Tailored information for researchers. All content is for in-vitro / preclinical research context only — not medical advice.

Mechanism of Action

Synthetic heptapeptide analog of tuftsin (Thr-Lys-Pro-Arg-Pro-Gly-Pro). Modulates GABAergic and serotonergic tone, upregulates BDNF expression, and shifts cytokine balance (IL-6, IFN, IL-2) toward an immunomodulatory profile — without sedation, dependence, or withdrawal observed with benzodiazepine-class agents.

How It Helps

Studied for anxiolytic activity that preserves alertness, mood stabilization, attention under stress, and immune balance during prolonged psychological or physical load.

Half-Life

Short plasma half-life (minutes); downstream neurochemical effects persist for hours per dose.

Onset of Effects

Calming effect commonly reported within 20–60 minutes intranasally; cumulative mood effects build over 1–3 weeks.

Administration

Intranasal is the standard published route. Subcutaneous injection is used in some research protocols.

Storage

Lyophilized: 2–8°C short-term, –20°C long-term. Reconstituted: refrigerate 2–8°C, use within 28 days.

Reconstitution Guide

10 mg vial + 1 mL bacteriostatic water → 10 mg/mL (≈300 mcg per 0.03 mL). Transfer to a sterile intranasal dropper for measured delivery.

Precise Dosing Protocols

Anxiolytic research (standard)

Dose:
300–900 mcg per administration
Frequency:
1–3× daily intranasal
Duration:
2–4 week cycles

Acute stress models

Dose:
600 mcg
Frequency:
Single intranasal dose before stressor
Duration:
As needed within study window

Stacks Well With

  • ›Semax (cognitive + anxiolytic synergy)
  • ›BPC-157 (systemic stress recovery)
  • ›NAD+ (energy support)

Research-Observed Side Effects

  • •Mild nasal dryness or irritation
  • •Occasional transient drowsiness at higher doses
  • •Rarely: mild GI upset

Translational Cautions

  • •Concurrent benzodiazepine or sedative protocols without specialist oversight
  • •Active pregnancy in human translational models

Cycling Guidance

2–4 weeks on, 1–2 weeks off is the most common pattern; chronic use research suggests favorable tolerance vs benzodiazepine-class comparators.

Research Highlights

  • ▸Russian clinical literature: anxiolytic efficacy comparable to medazepam without sedation, ataxia, or withdrawal.
  • ▸Documented modulation of serum BDNF and balance of IL-6 / IFN cytokines.
  • ▸Preclinical models: attention and adaptive behavior preserved under chronic stress.

Researcher FAQ